Human Insulin Secreted from Insulinogenic Xenograft Restores Normoglycemia in Type 1 Diabetic Mice without Immunosuppression

In the present study, we examined the therapeutic potential of human amnion-derived insulin-secreting cells for type 1 diabetes. Human amniotic mesenchymal stem cells (hAMs) were isolated from amnion and cultivated to differentiate into insulin-secreting cells in vitro. After culture in vitro, the d...

Full description

Bibliographic Details
Main Authors: J. Kim, S. Park, H. M. Kang, C. W. Ahn, H. C. Kwon, J. H. Song, Y. J. Lee, K. H. Lee, H. Yang, S. Y. Baek, S. H. Yoo, S. H. Kim, H. Kim
Format: Article
Language:English
Published: SAGE Publishing 2012-10-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368912X636803